Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SDT-001
- Development stage
- Unknown
- Lead developer
- Akili Interactive
- Administration
- Digital
01
Overview
SDT-001 is a digital therapeutic application developed by Akili and exclusively licensed to Shionogi for clinical development, commercialization, and distribution in Japan and Taiwan. It is designed as a smartphone or tablet app to improve attentional functioning in pediatric patients with attention-deficit/hyperactivity disorder (ADHD). The therapy utilizes Akili's Selective Stimulus Management Engine (SSME) core technology to deliver optimized dual tasks tailored to individual patients, aiming to activate the prefrontal cortex—a key region for cognitive functions—thereby improving attentional control. In Phase 3 clinical trials involving children aged 6–17 with ADHD who were also receiving conventional treatments, SDT-001 demonstrated statistically significant improvements in inattentiveness and hyperactivity/impulsivity scores compared to controls. No serious adverse events or safety concerns were observed. The product has been submitted for marketing approval in Japan based on these results[1][3][5].
- Brand names
- ENDEAVORRIDE
- Other names
- SDT-001SDT001SDT 001ENDEAVORRIDE
Beyond the preview
Go deeper on SDT-001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SDT-001.